Obagi Medical
$50.00 · Serum
Your profile match
Community
Not enough reports yet (0/3).
Ideal for
Not recommended for
Caution
May aggravate: Psoriasis (Fragrance); Perioral Dermatitis (Fragrance); Melasma (Fragrance and Menthol)
Set up a profile to see which of these apply to you.
2% Salicylic Acid: neutralizes acne-causing bacteria to prevent and heal breakouts Glycerin: soothes irritation and reduces inflammation Due to a manufacturer packaging change, item received may vary from product image. Learn more on the blog: Everything You Wanted to Ask About Acne, Answered!
Obagi CLENZIderm M.D. Pore Therapy features a medicated formula to promote skin clarity by keeping pores clear and controlling excess oil production. With regular use, this skin tone helps your complexion become balanced, clear and refreshed. Key
Clean skin thoroughly before applying medication. Moisten a cotton ball with the Obagi CLENZIderm M.D. Pore Therapy and smooth the cotton ball over your face. Use AM and PM. Allow to dry. If bothersome drying occurs, reduce application to once a day or every other day.
Key actives
Active: Salicylic Acid 2%. Inactive: Benzalkonium Chloride, Benzyl Alcohol, Ethoxydiglycol, Ext. Violet 2 (CI 60730), Fragrance, Glycerin, Menthol, Menthoxypropanediol, Menthyl Lactate, SD Alcohol 40-B (Alcohol Denat.), Water (Aqua). For the latest information, it is recommended to review the ingredient list printed on the packaging of the product prior to usage or consumption.
35 studies on 6of this product’s ingredients. These study the ingredient, not this product.
Dermatology and Therapy, 2015 · n=120 · systematic-review
Systematic review of keratolytics and emollients in psoriasis therapy: salicylic acid is a key keratolytic that removes psoriatic scale and improves penetration of co-applied topical agents; supports salicylic acid as an evidence-based adjunctive (descaling) treatment rather than a standalone therapy.
Clinical, Cosmetic and Investigational Dermatology, 2015 · systematic-review
Comprehensive review: salicylic acid (2%) is the only lipophilic BHA, enabling comedolytic and anti-inflammatory activity within the pilosebaceous unit; effective for acne vulgaris, melasma, photodamage, and keratosis pilaris; 20-30% SA peels show efficacy comparable to glycolic acid peels with lower erythema risk in Fitzpatrick IV-VI
Journal of the European Academy of Dermatology and Venereology, 2011 · n=50 · rct
Single-blind RCT (n=46, 12 weeks) in mild-to-moderate acne comparing salicylic acid 3% plus clindamycin with tretinoin 0.05% plus clindamycin: both significantly reduced inflammatory and non-inflammatory lesion counts; tretinoin acted faster (significant by week 2) but groups were comparable at 12 weeks, and both were well tolerated.
Used this product? Sign in to share your outcome and see what people with your skin reported.
Sign in to add your experienceNo reports yet. Be the first to share your experience.
Community outcomes are self-reported member experiences, shown separately from the evidence score — never blended into it. Educational, not medical advice.